Pro Medicus Announces On-Market Buy-Back
Key points
- Pro Medicus to buy back up to 10% of its shares
- Buy-back to commence on 1 April 2026 and end on 31 March 2027
- Broker appointed to facilitate the buy-back
Full summary
Pro Medicus Limited, a leading provider of healthcare imaging solutions, has announced an on-market buy-back of up to 10,446,996 of its ordinary fully paid shares, representing approximately 10% of its total issued capital. The buy-back will commence on 1 April 2026 and end on 31 March 2027. The company has appointed Goldman Sachs as the broker to facilitate the buy-back. The buy-back is being undertaken to enhance shareholder value and provide an opportunity for shareholders to sell their shares on-market if they choose to do so. Pro Medicus will fund the buy-back from its existing cash reserves. The buy-back is not subject to shareholder approval and will be conducted in accordance with the Corporations Act 2001 and the ASX Listing Rules.
Summary generated by a large language model. Please interpret with care.